Skin, speech, and brain scans may unmask hidden neurodegeneration

NCT ID NCT06467461

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This study investigates whether a combination of skin biopsies, speech analysis, and ultra-high field 7T MRI can detect early signs of Parkinson's disease and dementia with Lewy bodies. It focuses on people with a specific type of REM sleep behavior disorder triggered by serotonergic antidepressants, which may be an early warning sign. The research will compare these individuals to matched controls over 30 months to see if these tests can identify underlying neurodegeneration.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Skin biopsy, speech testing, and ultra-high field 7T MRI as diagnostic tools
What this could lead to
If successful, this could lead to earlier detection of Parkinson's disease and Lewy body dementia, potentially enabling earlier intervention and better management.
What could go wrong
This is an early-stage diagnostic study with a small sample size. The tests may not reliably distinguish those who will develop neurodegeneration from those who won't, and results may not generalize to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIA WITH LEWY BODIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Minnesota

    Minneapolis, Minnesota, 55455, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.